Lena Wijk1, Karin Franzen, Olle Ljungqvist, Kerstin Nilsson. 1. Department of Obstetrics and Gynecology, Örebro University, Örebro, Sweden; School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Abstract
OBJECTIVE: To study the effects of introducing an Enhanced Recovery After Surgery (ERAS) protocol, modified for gynecological surgery, on length of stay and complications following abdominal hysterectomy. DESIGN: Observational study. SETTING: Department of Obstetrics and Gynecology, Örebro University Hospital, Sweden. POPULATION: Eighty-five patients undergoing abdominal hysterectomy for benign or malignant indications between January and December 2012, with or without salpingo-oophorectomy. Outcomes were compared with all consecutive patients who had undergone the same surgery from January to December 2011, immediately before establishing the ERAS protocol (n = 120). METHODS: The ERAS protocol was initiated in January 2012 as part of a targeted implementation program. Data were extracted from patient records and from a specific database. MAIN OUTCOME MEASURES: Length of stay and the proportion of patients achieving target length of stay (2 days). RESULTS: Length of stay was significantly reduced in the study population after introducing the ERAS protocol from a mean of 2.6 (SD 1.1) days to a mean of 2.3 (SD 1.2) days (p = 0.011). The proportion of patients discharged at 2 days was significantly increased from 56% pre-ERAS to 73% after ERAS (p = 0.012). No differences were found in complications (5% vs. 3.5% in primary stay, 12% vs. 15% within 30 days after discharge), reoperations (2% vs. 1%) or readmission (4% vs. 4%). CONCLUSIONS: Introducing the ERAS protocol for abdominal hysterectomy reduced length of stay without increasing complications or readmissions.
OBJECTIVE: To study the effects of introducing an Enhanced Recovery After Surgery (ERAS) protocol, modified for gynecological surgery, on length of stay and complications following abdominal hysterectomy. DESIGN: Observational study. SETTING: Department of Obstetrics and Gynecology, Örebro University Hospital, Sweden. POPULATION: Eighty-five patients undergoing abdominal hysterectomy for benign or malignant indications between January and December 2012, with or without salpingo-oophorectomy. Outcomes were compared with all consecutive patients who had undergone the same surgery from January to December 2011, immediately before establishing the ERAS protocol (n = 120). METHODS: The ERAS protocol was initiated in January 2012 as part of a targeted implementation program. Data were extracted from patient records and from a specific database. MAIN OUTCOME MEASURES: Length of stay and the proportion of patients achieving target length of stay (2 days). RESULTS: Length of stay was significantly reduced in the study population after introducing the ERAS protocol from a mean of 2.6 (SD 1.1) days to a mean of 2.3 (SD 1.2) days (p = 0.011). The proportion of patients discharged at 2 days was significantly increased from 56% pre-ERAS to 73% after ERAS (p = 0.012). No differences were found in complications (5% vs. 3.5% in primary stay, 12% vs. 15% within 30 days after discharge), reoperations (2% vs. 1%) or readmission (4% vs. 4%). CONCLUSIONS: Introducing the ERAS protocol for abdominal hysterectomy reduced length of stay without increasing complications or readmissions.
Authors: Ross F Harrison; Yao Li; Alexis Guzman; Brandelyn Pitcher; Andrea Rodriguez-Restrepo; Katherine E Cain; Maria D Iniesta; Javier D Lasala; Pedro T Ramirez; Larissa A Meyer Journal: Am J Obstet Gynecol Date: 2019-07-31 Impact factor: 8.661
Authors: Elisa Rodriguez Trowbridge; Sarah L Evans; Bethany M Sarosiek; Susan C Modesitt; Dana L Redick; Mohamed Tiouririne; Robert H Thiele; Traci L Hedrick; Kathie L Hullfish Journal: Int Urogynecol J Date: 2018-10-29 Impact factor: 2.894
Authors: Timothy L Fitzgerald; Catalina Mosquera; Nicholas J Koutlas; Nasreen A Vohra; Kimberly V Edwards; Emmanuel E Zervos Journal: Surg Res Pract Date: 2016-08-25
Authors: Tanvi V Joshi; Shaina F Bruce; Rod Grim; Tommy Buchanan; Sudeshna Chatterjee-Paer; Elizabeth R Burton; Joel I Sorosky; Mark S Shahin; Mitchell I Edelson Journal: Gynecol Oncol Rep Date: 2021-04-30